Fabrice Cabaud Investment thesis Bio-Rad Laboratories, Inc. (NYSE:BIO) is a multinational manufacturer and distributor of life science research and clinical diagnostics products. The company operates through two primary segments: Life Sciences (“LS”) and Clinical Diagnostics (“CD”), providing tools for biological research and clinical diagnostics. Since FY’21, the company’s stock has been hammered due to a […]
The post Bio-Rad: Economics Unsupportive With Capital Valued 70 Cents On The Dollar (NYSE:BIO) appeared first on News Portal NYC.
